President Trump has promoted the company’s antibody treatment in recent videos.
that a clinical trial for its antibody treatment for Covid-19 has been paused because of a “potential safety concern,” just one day after Johnson & Johnson halted its Covid-19 vaccine trial because a participant got sick.Eli Lilly is testing how hundreds of people hospitalized with Covid-19 react to its antibody therapy compared with a placebo; all study participants also receive the experimental drug remdesivir.
Multiple government officials reportedly sent emails to researchers Tuesday to tell them to stop enrolling new participants out of an “abundance of caution,” according to thethe company supports the decision the independent oversight committee Data and Safety Monitoring Board made to pause the study to “cautiously ensure” the safety of participants.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly pauses trial of its monoclonal antibody to treat Covid-19 for safety reasonsThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »
Eli Lilly antibody trial paused due to potential safety concernU.S. drugmaker Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been paused because of a safety concern.
Read more »
Eli Lilly antibody trial paused due to potential safety concern"Out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has recommended a pause in enrollment," Lilly spokeswoman Molly McCully said in an emailed statement. "Lilly is supportive of the decision by the independent DSMB to cautiously ensure the safety
Read more »
U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns
Read more »
Eli Lilly antibody trial paused due to potential safety concernU.S. drugmaker Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been paused because of a safety concern.
Read more »
Eli Lilly antibody trial paused due to potential safety concern"Out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has recommended a pause in enrollment," Lilly spokeswoman Molly McCully said in an emailed statement. "Lilly is supportive of the decision by the independent DSMB to cautiously ensure the safety
Read more »